Regarding the research on 417 COVID-19 patients, 76.3% had abnormal liver tests and 21.5% had a liver injury during hospitalization.42 Studies have shown abnormal levels of alanine aminotransferase, aspartate aminotransferase (AST), and bilirubin in 14.8–53% of COVID-19 patients. This evidence concerns the gene GPT and COVID-19.